WHO-ILAR-COPCORD in the Asia-Pacific: the past, present and future

被引:13
作者
Haq, Syed Atiqul [1 ]
Rasker, Johannes J. [2 ]
Darmawan, John [3 ]
Chopra, Arvind [4 ]
机构
[1] BSM Med Univ, Dept Med, Dhaka, Bangladesh
[2] Fac Hlth Sci, Enschede, Netherlands
[3] Indonesia Rheumat Ctr, WHO Collaborating Ctr, Semarang Jakarta, Indonesia
[4] Ctr Rheumat Dis, Pune, Maharashtra, India
关键词
Asia-Pacific; COPCORD; musculoskeletal disorders; pain; rheumatology;
D O I
10.1111/j.1756-185X.2008.00321.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The aim of the Community Oriented Program for Control of Rheumatic Disorders (COPCORD) is reduction of community burden of rheumatic disorders, particularly in developing communities. Stage I entails estimation of prevalence and incidence of musculoskeletal pain and rheumatic disorders. Stage II is dedicated to education of health workers, patients and the community. Stage III deals with identification of risk factors for common rheumatic disorders and development of strategies for their primary and secondary prevention. So far Stage I data have been reported from 15 countries in the Asia-Pacific countries. The prevalence of musculoskeletal pain has varied from 11.6% to 45.4%. The commonest sites of pain were low back, knee, neck and shoulder. Commonest rheumatic disorders were osteoarthritis of knees, non-specific low back pain and soft tissue rheumatism. A few scattered educational activities have been reported from Indonesia and India. Systematic case-controlled or cohort studies aimed at finding out the risk factors for common rheumatic disorders were scanty. However, several associations were reported from cross-sectional prevalence surveys. It is imperative that the COPCORD investigators in the Asia-Pacific region focus on finding out the modifiable risk factors for rheumatic disorders with properly designed studies, develop preventive strategies on the basis of identified risk factors and carry out interventional studies to test the efficacy of the strategies with validated outcome instruments.
引用
收藏
页码:4 / 10
页数:7
相关论文
共 46 条
[1]
Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis [J].
AbdelNasser, AM ;
Rasker, JJ ;
Valkenburg, HA .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1997, 27 (02) :123-140
[2]
ABDELNASSER AM, 2006, APLAR J RHEUMATOLO S, V9, pA58
[3]
Al-Awadhi A, 2002, J RHEUMATOL, V29, P1754
[4]
Al-Awadhi AM, 2004, CLIN EXP RHEUMATOL, V22, P177
[5]
DEVELOPMENT OF CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS - CLASSIFICATION OF OSTEOARTHRITIS OF THE KNEE [J].
ALTMAN, R ;
ASCH, E ;
BLOCH, D ;
BOLE, G ;
BORENSTEIN, D ;
BRANDT, K ;
CHRISTY, W ;
COOKE, TD ;
GREENWALD, R ;
HOCHBERG, M ;
HOWELL, D ;
KAPLAN, D ;
KOOPMAN, W ;
LONGLEY, S ;
MANKIN, H ;
MCSHANE, DJ ;
MEDSGER, T ;
MEENAN, R ;
MIKKELSEN, W ;
MOSKOWITZ, R ;
MURPHY, W ;
ROTHSCHILD, B ;
SEGAL, M ;
SOKOLOFF, L ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1986, 29 (08) :1039-1049
[6]
Chaiamnuay P, 1998, J RHEUMATOL, V25, P1382
[7]
Chen SL, 1998, CHINESE MED J-PEKING, V111, P228
[8]
Chen SL, 1992, APLAR RHEUMATOLOGY, P393
[9]
Chopra A, 2000, ARTHRITIS RHEUM, V43, pS71
[10]
Chopra A, 2004, J RHEUMATOL, V31, P2320